Okumura, T.; Kimura, T.; Iwadare, T.; Wakabayashi, S.-i.; Kobayashi, H.; Yamashita, Y.; Sugiura, A.; Joshita, S.; Fujimori, N.; Kunimoto, H.;
et al. Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study. Cancers 2023, 15, 5343.
https://doi.org/10.3390/cancers15225343
AMA Style
Okumura T, Kimura T, Iwadare T, Wakabayashi S-i, Kobayashi H, Yamashita Y, Sugiura A, Joshita S, Fujimori N, Kunimoto H,
et al. Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study. Cancers. 2023; 15(22):5343.
https://doi.org/10.3390/cancers15225343
Chicago/Turabian Style
Okumura, Taiki, Takefumi Kimura, Takanobu Iwadare, Shun-ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Satoru Joshita, Naoyuki Fujimori, Hideo Kunimoto,
and et al. 2023. "Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study" Cancers 15, no. 22: 5343.
https://doi.org/10.3390/cancers15225343
APA Style
Okumura, T., Kimura, T., Iwadare, T., Wakabayashi, S.-i., Kobayashi, H., Yamashita, Y., Sugiura, A., Joshita, S., Fujimori, N., Kunimoto, H., Komatsu, M., Fukushima, H., Mori, H., & Umemura, T.
(2023). Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study. Cancers, 15(22), 5343.
https://doi.org/10.3390/cancers15225343
